25 of the Best Oncologists Near Me

Dr. Janet S. Rader became the Jack A. & Elaine D. Klieger Professor and Chair of the Department of Obstetrics and Gynecology at the Medical College of Wisconsin in September 2009. She received her Doctor of Medicine degree from the University of Missouri. She completed her residency in Obstetrics and Gynecology at Michael Reese Hospital and Medical Center. She did a Fellowship in Gynecologic Oncology at the Johns Hopkins University Hospital. She is board certified in obstetrics and gynecology and gynecologic oncology.Named in U.S. News & World Report’s Top Doctors List, Dr. Rader is ranked in the top 1% of Gynecologic Oncologists nationwide. Dr. Rader’s practice involves chemotherapy and surgery (including laparoscopic/robotic procedures). She specializes in cervical, ovarian, and uterine cancers, gestational trophoblastic disease, pelvic masses, cancer screening and prevention.In addition to leading the department, Dr. Rader provides leadership in development of a Women’s Health Research Program and while continuing her own research program in gynecologic cancers.She has received National Institutes of Health (NIH) and American Cancer Society (ACS) funding for her research. Her research focuses on developing new therapies for gynecologic cancer through clinical trials and analysis of molecular changes in gynecologic malignancies.Dr. Rader over 190 peer reviewed publications and 26 book chapters/editorials/reviews. Dr. Rader is highly rated in 10 conditions, according to our data. Her clinical expertise encompasses Endometrial Cancer, Ovarian Cancer, Ovarian Carcinosarcoma, Hysterectomy, and Salpingo-Oophorectomy. Dr. Rader is board certified in Obstetrics And Gynecology and Gynecologic Oncology. Dr. Rader is currently accepting new patients.

Michael Bidus, MD, provides gynecologic oncologic services at Avera Medical Group Gynecologic Oncology in Sioux Falls, SD. Dr. Bidus is highly rated in 10 conditions, according to our data. His clinical expertise encompasses Malignant Mixed Mullerian Tumor, Virilizing Ovarian Tumor, Ovarian Carcinosarcoma, Splenectomy, and Hernia Surgery. Dr. Bidus is board certified in American Board Of Obstetrics And Gynecology American Board Of Obstetrics And Gynecology, Subspecialty In Gynecologic Oncology. Dr. Bidus is currently accepting new patients.

Balazs Halmos, MD received his medical degree summa cum laude from Semmelweis University in Budapest, Hungary. He completed an internal medicine residency program at St. Dr. Halmos is highly rated in 9 conditions, according to our data. His clinical expertise encompasses Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), EGFR Positive Lung Cancer, Small Cell Lung Cancer (SCLC), and Tissue Biopsy. Dr. Halmos is currently accepting new patients.

Dr. Benjamin Levy is a thoracic medical oncologist and the clinical director of medical oncology for the Johns Hopkins Sidney Kimmel Cancer Center at Sibley Memorial Hospital, as well as an associate professor of oncology for Johns Hopkins University School of Medicine. He practices out of the Johns Hopkins Sidney Kimmel Cancer Center at Sibley Memorial Hospital. Dr. Levy is a physician scientist who is interested in innovative immunotherapeutic approaches for advanced stage lung cancer patients and biomarkers that help define those patients more likely to respond to such agents. He has an expertise in thoracic malignancies, including non-small cell lung cancer, small cell lung cancer and thymic malignancies, as well as head and neck cancer. Dr. Levy earned his medical degree from Medical College of Georgia. He completed an internal medicine residency at Georgetown University Hospital, followed by a hematology/oncology fellowship at New York Presbyterian/Weill Cornell Medical Center, where he received the Department of Medicine Research Fellow of the Year Award and the 2009 American Society of Clinical Oncology Young Investigator Award for his clinical research in prostate cancer. Dr. Levy previously worked as an assistant professor at the Icahn School of Medicine, medical director of thoracic oncology for Mount Sinai Health Systems and associate director of the Cancer Clinical Trials Office for Mount Sinai Hospital in New York City. Dr. Levy played an integral role on several American Society of Clinical Oncology (ASCO) committees and currently serves as associate editor for the ASCO University Committee. He completed a two year term on the editorial board for the Journal of Clinical Oncology and currently serves as an ad hoc reviewer for other journals, including Clinical Lung Cancer, The Oncologist and Oncotarget. Dr. Levy was recently selected as one of only 15 oncologists in the country to the prestigious ASCO Leadership Development program, whose mission is to identify and develop future leaders of ASCO. In addition to his ASCO commitments, Dr. Levy serves on the ALLIANCE Respiratory Committee, the IASLC Staging Committee and the IASLC Career Development & Fellowship Committee. Dr. Levy is highly rated in 9 conditions, according to our data. His clinical expertise encompasses Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), Squamous Cell Lung Carcinoma, EGFR Positive Lung Cancer, and Tissue Biopsy. Dr. Levy is board certified in American Board Of Internal Medicine. Dr. Levy is currently accepting new patients.

Larisa Geskin is an Oncologist practicing medicine in White Plains, New York. Dr. Geskin is highly rated in 9 conditions, according to our data. Her clinical expertise encompasses Cutaneous T-Cell Lymphoma (CTCL), T-Cell Lymphoma, Non-Hodgkin Lymphoma, and Melanoma. Dr. Geskin is currently accepting new patients.

Dr. Wolpin received his medical degree from Harvard Medical School in 2001. He subsequently completed his residency in Internal Medicine at Brigham and Women's Hospital, and his fellowship in Medical Oncology at the Dana-Farber Cancer Institute. He joined the staff of DFCI and Brigham and Women's Hospital in 2007, where he is a medical oncologist and clinical investigator in the Center for Gastrointestinal Oncology. His research focuses on biomarkers and novel therapeutics in gastrointestinal malignancies, and mechanisms by which lifestyle factors interact with malignant risk and progression. Dr. Wolpin is highly rated in 9 conditions, according to our data. His clinical expertise encompasses Pancreatic Cancer, Pancreatic Ductal Adenocarcinoma, Colorectal Cancer, Pancreaticoduodenectomy, and Pancreatectomy. Dr. Wolpin is board certified in Medical Oncology. Dr. Wolpin is currently accepting new patients.

Dr. Devarakonda trained and worked on faculty at the Washington University in St. Louis before joining Swedish. His research is focused on understanding cancers utilizing sequencing technologies. He has an excellent understanding of the latest advances in thoracic oncology (lung cancer, thymic malignancies, mesothelioma). He believes in providing the same level of care for his patients that he expects for his own family. His list of peer-reviewed scientific publications can be accessed here https://pubmed.ncbi.nlm.nih.gov/?term=Devarakonda+S&cauthor_id=34591593. Dr. Devarakonda is highly rated in 9 conditions, according to our data. His clinical expertise encompasses Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), Small Cell Lung Cancer (SCLC), and Lung Adenocarcinoma. Dr. Devarakonda is board certified in American Board Of Internal Medicine. Dr. Devarakonda is currently accepting new patients.

Dr. Samuel Denmeade is the R. Dale Hughes Professor of Oncology and Urology at the Johns Hopkins University School of Medicine and Director of the Genitourinary Oncology Division for the Johns Hopkins Kimmel Cancer Center. He also has appointments in the Department of Pharmacology and Molecular Sciences and Department of Biomolecular Engineering. His areas of clinical expertise include bladder cancer, kidney cancer, prostate cancer and testicular cancer. Dr. Denmeade earned his M.D. from the Columbia College of Physicians and Surgeons of Columbia University. He completed his residency at the University of Chicago. He performed a fellowship in oncology at The Johns Hopkins Hospital and a fellowship in medical oncology at the Johns Hopkins University School of Medicine. His research interests include prostate cancer, bipolar androgen therapy, clinical trials and targeted drug development. Dr. Denmeade has published over 200 papers in the area of prostate cancer research. He has received extensive funding from the NIH, the Department of Defense Prostate Cancer Research Fund and the Prostate Cancer Foundation. He is the Editor-in-Chief of the medical journal The Prostate. Dr. Denmeade is highly rated in 9 conditions, according to our data. His clinical expertise encompasses Prostate Cancer, Familial Prostate Cancer, Renal Cell Carcinoma (RCC), Hormone Replacement Therapy (HRT), and Prostatectomy. Dr. Denmeade is board certified in American Board Of Internal Medicine. Dr. Denmeade is currently accepting new patients.

Jamie Lesnock, MD, specializes in gynecologic oncology and is certified in gynecologic oncology and obstetrics and gynecology by the American Board of Obstetrics and Gynecology. She practices at University of Pittsburgh Physicians, Department of Obstetrics and Gynecology and is affiliated with UPMC Mercy, UPMC Presbyterian, UPMC Shadyside, UPMC Magee-Womens Hospital, and UPMC Passavant. She completed her residency at University of Pittsburgh School of Medicine and her medical degree at Vanderbilt University School of Medicine. Dr. Lesnock is highly rated in 9 conditions, according to our data. Her clinical expertise encompasses Endometrial Cancer, Ovarian Cancer, Ovarian Carcinosarcoma, Ureteral Reconstruction, and Tissue Biopsy. Dr. Lesnock is board certified in American Board Of Obstetrics And Gynecology and American Board Of Obstetrics And Gynecology. Dr. Lesnock is currently accepting new patients.

Dung Le, M.D. is a professor of oncology at the Johns Hopkins University School of Medicine and member of the Johns Hopkins Kimmel Cancer Center. Her research interests include novel approaches to patients with gastrointestinal malignancies. She has served as the principal investigator (PI) on many clinical trials focused on testing immunotherapy in patients with gastrointestinal malignancies and she has also served as the national PI on several studies including: anti-programmed death-1 (PD-1) in tumors with mismatch repair deficiency; a clinical trial in advanced pancreatic cancer patients evaluating the safety, tolerability and immune response to CRS-207, a listeria vaccine platform which has been modified to express the tumor antigen mesothelin; a multi-center, phase 2 study testing CRS-207 as a boost to allogenic pancreatic tumor cells transfected with GM-CSF gene (GVAX) for treatment of advanced pancreatic adenocarcinoma (PDA); a trial testing GVAX/ipilimumab in the maintenance setting for metastatic pancreatic cancer; and GVAX/CRS-207 +/- nivolumab in metastatic pancreatic cancer. These studies incorporate extensive laboratory correlates and have involved collaborations with clinicians and bench scientists with expertise in the fields of immunotherapy and cancer genomics. Dr. Le is highly rated in 9 conditions, according to our data. Her clinical expertise encompasses Pancreatic Cancer, Colorectal Cancer, Gastroesophageal Junction Cancer, and Familial Pancreatic Cancer. Dr. Le is board certified in American Board Of Internal Medicine. Dr. Le is currently accepting new patients.

Dr. Kristen Marrone is a thoracic medical oncology specialist in Baltimore, caring for patients with lung cancer and esophageal cancer. She is the Program Director of the Hematology/Medical Oncology Fellowship Program at the Johns Hopkins School of Medicine. Dr. Marrone received her undergraduate degree in psychology with a neuroscience concentration from Pennsylvania State University. She earned her M.D. from Drexel University College of Medicine. She completed her residency at Yale-New Haven Hospital and performed a fellowship in medical oncology at Johns Hopkins University School of Medicine. Dr. Marrone joined the Johns Hopkins faculty in 2017. Her research interests include clinical trial development and translational studies focusing on optimization of immunotherapy in oncogene driven non-small cell lung cancer. Dr. Marrone is a member of the American Association of Cancer Research, the American Society of Clinical Oncology, the International Association for Study of Lung Cancer and the Society for Immunotherapy in Cancer. Dr. Marrone is highly rated in 9 conditions, according to our data. Her clinical expertise encompasses Non-Small Cell Lung Cancer (NSCLC), Lung Cancer, Small Cell Lung Cancer (SCLC), and EGFR Positive Lung Cancer. Dr. Marrone is board certified in American Board Of Internal Medicine. Dr. Marrone is currently accepting new patients.

Dr. Ghiaur, a member of the Johns Hopkins Kimmel Cancer Center, is a physician-scientist whose primary interest is normal and malignant hematopoiesis, especially the role of the microenvironment in cell extrinsic drug resistance and persistence of minimal residual disease. He has distinguished himself as an outstanding laboratory-based investigator and a superior clinician. His research has translational potential in stem cell therapeutics, as well as acute leukemia and multiple myeloma. Dr. Ghiaur is highly rated in 9 conditions, according to our data. His clinical expertise encompasses Acute Myeloid Leukemia (AML), Acute Promyelocytic Leukemia, Acute Myeloblastic Leukemia without Maturation, Bone Marrow Aspiration, and Bone Marrow Transplant. Dr. Ghiaur is board certified in American Board Of Internal Medicine. Dr. Ghiaur is currently accepting new patients.

Richard O'neal is an Oncologist and a Hematologist Oncology provider practicing medicine in Greenville, South Carolina. Dr. O'neal is highly rated in 9 conditions, according to our data. His clinical expertise encompasses Squamous Cell Lung Carcinoma, ALK-Positive Non-Small Cell Lung Cancer, Lung Adenocarcinoma, and Small Cell Lung Cancer (SCLC). Dr. O'neal is board certified in American Board Of Internal Medicine. Dr. O'neal is currently accepting new patients.

Riaz Elahi is a Hematologist and an Oncologist practicing medicine in Hazel Crest, Illinois. Dr. Elahi is highly rated in 9 conditions, according to our data. His clinical expertise encompasses Multiple Myeloma, Breast Cancer, Paget Disease of the Breast, and Pleuropulmonary Blastoma. Dr. Elahi is board certified in American Board Of Internal Medicine, Hematology. Dr. Elahi is currently accepting new patients.

Dr. Shah is a multiple time recipient of the Seattle Magazine and Seattle Metropolitan Magazine Top Doctor Award including the Seattle Metropolitan Best of the Best Top Doctor Designation. Dr. Shah endeavors to provide comprehensive, thoughtful and dedicated level of care to women with or at risk for gynecologic cancers and their families. As a gynecologic oncologist, he is in the unique position of being able to provide comprehensive, personalized care. Whether a condition calls for surgery, chemotherapy or radiation treatment, Dr. Shah aims to be the primary care provider for a woman’s oncologic concerns. Having completed training in advanced surgical techniques (including robotic surgery), radical abdominal procedures and cutting-edge research, his goal is to treat his patients with the most current, effective and state-of-the-art treatment options available. Dr. Shah is highly rated in 9 conditions, according to our data. His clinical expertise encompasses Malignant Mixed Mullerian Tumor, Endometrial Cancer, Testicular Yolk Sac Tumor, and Ovarian Carcinosarcoma. Dr. Shah is board certified in American Board Of Obstetrics And Gynecology, Gynecologic Oncology, and Obstetrics & Gynecology. Dr. Shah is currently accepting new patients.

Elizabeth Pelkofski is an Oncologist practicing medicine in Cooperstown, New York. She has been practicing medicine for over 18 years. Dr. Pelkofski is highly rated in 9 conditions, according to our data. Her clinical expertise encompasses Vulvar Cancer, Malignant Mixed Mullerian Tumor, Endometrial Cancer, Ovarian Cancer, and Bladder Reconstruction. Dr. Pelkofski is board certified in American Board Of Obstetrics And Gynecology (Obstetrics & Gynecology, Gynecologic Oncology). Dr. Pelkofski is currently accepting new patients.

As a specialist in gynecologic cancers, including uterine, ovarian, cervical, vaginal, and vulvar cancers, I take care of women from the time of diagnosis, perform their surgeries if needed, and coordinate chemotherapy and/or radiation therapy according to the treatment plan we set out together. I have experience with a wide variety of surgical techniques, including robotic and laparoscopic approaches tailored to meet the individual needs of each patient. I strongly believe that cancer care continues from the time of diagnosis all the way through survivorship. I try to focus on clear communication and discussion of all of the appropriate treatment options to determine what makes the most sense for each individual woman. Duke has been a wonderful place to work because of the diverse and talented team members encompassing every part of women's cancer care. We are also conducting exciting research to determine how best to treat women with cancer or at risk of cancer. Outside of work, I spend as much time as possible with friends and family as well as yoga, biking, and traveling. Dr. Mcnally is highly rated in 9 conditions, according to our data. Her clinical expertise encompasses Malignant Mixed Mullerian Tumor, Endometrial Cancer, Endometrial Stromal Sarcoma, and Vulvar Cancer. Dr. Mcnally is board certified in American Board Of Obstetrics/Gynecology, Obstetrics & Gynecology and American Board Of Obstetrics/Gynecology, Gynecologic Oncology. Dr. Mcnally is currently accepting new patients.

Nikhil Munshi is an Oncologist practicing medicine in Boston, Massachusetts. Dr. Munshi is highly rated in 8 conditions, according to our data. His clinical expertise encompasses Multiple Myeloma, Smoldering Multiple Myeloma, Castleman Disease, and Relapsed Refractory Multiple Myeloma (RRMM). Dr. Munshi is board certified in Internal Medicine and Medical Oncology. Dr. Munshi is currently accepting new patients.

Takami Sato is an Oncologist practicing medicine in Philadelphia, Pennsylvania. Dr. Sato is highly rated in 8 conditions, according to our data. His clinical expertise encompasses Metastatic Uveal Melanoma, Uveal Melanoma, Melanoma of the Eye, Melanoma, and Liver Embolization. Dr. Sato is currently accepting new patients.

Dr. Antonio Wolff is internationally recognized for his work on breast cancer biomarkers, including HER2. As a practicing oncologist and clinical translational researcher, his research has been pivotal to improve the quality of breast cancer biomarker testing in breast cancer, including HER2 and estrogen receptor testing. Among his leadership accomplishments is ensuring that sophisticated laboratory findings are translated into improved clinical care in breast cancer. He is a Fellow of the American Society of Clinical Oncology (ASCO), a Komen Scholar and a Breast Cancer Research Foundation investigator. He has served as associate editor for Journal of Clinical Oncology, and serves on the National Comprehensive Cancer Network (NCCN) Guideline Steering Committee. He is a leader of the Translational Breast Cancer Research Consortium (TBCRC), and one of the principal investigators of the Evolutionary Clinical Trial for Novel Biomarker-Driven Therapies (EVOLVE) in Metastatic Breast Cancer, which was one of the three disease groups recently awarded by ARPA-H to conduct innovative trials using Advanced Analysis for Precision Cancer Therapy (ADAPT). After many years of service as Breast Committee Chair in the ECOG-ACRIN Clinical Trial Network of the National Cancer Institute (NCI), he was elected in 2024 as Co-Chair of the NCI Breast Cancer Steering Committee and appointed to the international steering committee of the Oxford Overview Collaborative, which are positions aimed at advancing clinical trials in breast cancer. At Johns Hopkins, he is an elected member of the Miller Coulson Academy of Clinical Excellence and was honored during the 125th Anniversary Living the Hopkins Mission celebrations of the JHU School of Medicine. Dr. Wolff is highly rated in 8 conditions, according to our data. His clinical expertise encompasses Breast Cancer, HER-2 Positive Breast Cancer, Triple-Negative Breast Cancer, and Inflammatory Breast Cancer. Dr. Wolff is board certified in American Board Of Internal Medicine. Dr. Wolff is currently accepting new patients.

Dr. Leone received his MD from Universidad del Salvador, Argentina in 2005. He completed his residency in Internal Medicine at University of Miami Jackson Memorial Hospital in 2011, and went on to complete fellowships in Hematology and Medical Oncology at University of Pittsburgh Medical Center in 2014. He was faculty at University of Iowa Hospitals and Clinics from 2014 through 2017. In 2017, he joined the staff of Brigham and Women's Hospital and Dana-Farber, where he is a medical oncologist and clinical investigator in the Breast Oncology Center. His research focuses on brain metastases, male breast cancer and novel therapies in the treatment of breast cancer. Dr. Leone is highly rated in 8 conditions, according to our data. His clinical expertise encompasses Breast Cancer in Men, Breast Cancer, Inflammatory Breast Cancer, and Brain Tumor. Dr. Leone is board certified in Oncology. Dr. Leone is currently accepting new patients.

Angela Demichele is an Oncologist practicing medicine in Philadelphia, Pennsylvania. Dr. Demichele is highly rated in 8 conditions, according to our data. Her clinical expertise encompasses Breast Cancer, HER-2 Positive Breast Cancer, Paget Disease of the Breast, and Inflammatory Breast Cancer. Dr. Demichele is board certified in Medical Oncology, 1998. Dr. Demichele is currently accepting new patients.

Dr. Lynce received her medical degree from the Universidade Nova de Lisboa, Portugal in 2004. She completed her residency in Internal Medicine and fellowship in Hematology and Medical Oncology at MedStar Washington Hospital Center/MedStar Georgetown University Hospital in Washington, DC. She was faculty at MedStar Georgetown University Hospital from 2015 to 2020 where she served as the institutional PI for Alliance and the co-PI for the National Capital Area (NCA) Minority/Underserved NCORP. In 2020, she joined the staff of Dana-Farber Cancer Institute and Brigham and Women's Hospital, where she is a medical oncologist and clinical investigator in the Breast Oncology Center. Her research focuses on inflammatory breast cancer, triple-negative breast cancer, BRCA-associated breast cancers and novel therapies in the treatment of breast cancer. Dr. Lynce is highly rated in 8 conditions, according to our data. Her clinical expertise encompasses Inflammatory Breast Cancer, Breast Cancer, Triple-Negative Breast Cancer, Angiosarcoma, and Salpingo-Oophorectomy. Dr. Lynce is board certified in Medical Oncology. Dr. Lynce is currently accepting new patients.

David Chung is a Hematologist and an Oncologist practicing medicine in New York, New York. Dr. Chung is highly rated in 8 conditions, according to our data. His clinical expertise encompasses Multiple Myeloma, Smoldering Multiple Myeloma, Relapsed Refractory Multiple Myeloma (RRMM), Bone Marrow Transplant, and Bone Marrow Aspiration. Dr. Chung is board certified in American Board Of Internal Medicine/Medical Oncology. Dr. Chung is currently accepting new patients.

I am medical oncologist dedicated to the care of patients with genitourinary malignancies. My clinical and research focus is on the management of renal cell carcinoma (RCC). I have completed Medical Oncology Higher Specialist Training with Royal College of Physicians in Ireland and subsequently completed Advanced Medical Oncology Fellowship at the Memorial Sloan Kettering Cancer Center in New York. Dr. Ged is highly rated in 8 conditions, according to our data. His clinical expertise encompasses Renal Cell Carcinoma (RCC), Chromophobe Renal Cell Carcinoma, Wilms Tumor, Nephrectomy, and Thrombectomy. Dr. Ged is currently accepting new patients.